Medical Cannabis in Parkinson Disease: Real-Life Patients’ Experience
This originally appeared at https://pubmed.ncbi.nlm.nih.gov/29059132/ Authors Yacov Balash 1 , Lihi Bar-Lev Schleider, Amos D Korczyn, Herzel Shabtai, Judith Knaani, Alina Rosenberg, Yehuda Baruch, Ruth Djaldetti, Nir Giladi, Tanya Gurevich Abstract Background: The use of medical cannabis (MC) is controversial. Support for its benefits is based on small clinical series. Objective: The aim of this study was to report the results of a standardized […]
The relationship between cannabis use and IVF outcome—a cohort study
This originally appeared at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424823/ Authors Eden Har-Gil,1Ayala Heled,2Marjorie Dixon,3,4Abdul Munaf Sultan Ahamed,4 and Yaakov Bentov4,5,6 Abstract Background The effects of cannabis use on male and female reproduction have been the focus of scientific research for decades. Although initial studies raised concerns, more recent studies were reassuring. Considering the recent legalization of recreational use of […]
Therapeutic Prospects of Cannabidiol for Alcohol Use Disorder and Alcohol-Related Damages on the Liver and the Brain
This originally appeared at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554654/ Authors Julia De Ternay, 1 , * Mickaël Naassila, 2 Mikail Nourredine, 1 Alexandre Louvet, 3 François Bailly, 4 Guillaume Sescousse, 5 Pierre Maurage, 6 Olivier Cottencin, 7 Patrizia Maria Carrieri, 8 and Benjamin Rolland 1 , 5 , * Published 2019 May 31 doi: 10.3389/fphar.2019.00627 PMCID: PMC6554654 PMID: 31214036 Abstract […]
Effects of cannabis use on alcohol consumption in a sample of treatment-engaged heavy drinkers in Colorado
This originally appeared at https://pubmed.ncbi.nlm.nih.gov/33464670/ Authors Hollis C Karoly 1 2 , J Megan Ross 3 , Mark A Prince 2 , Alexandra E Zabelski 1 , Kent E Hutchison 1 3 4 PMID: 33464670 PMCID: PMC8286984 DOI: 10.1111/add.15407 Abstract Background and Aims. Cannabis is commonly used among people who drink alcohol, but evidence suggests a […]
Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1
This article originally appeared at https://www.sciencedirect.com/science/article/abs/pii/S0006295214004201 Authors Institute of Toxicology and Pharmacology, University of Rostock, Rostock, GermanybSection of Molecular Oncology and Immunotherapy, Department of General Surgery, University of Rostock, Rostock, GermanycDepartment of Radiotherapy and Radiation Oncology, University of Rostock, Rostock, Germany https://doi.org/10.1016/j.bcp.2014.07.014 Abstract Cannabinoids have been shown to promote the expression of the intercellular adhesion […]
Reduction of Benzodiazepine Use in Patients Prescribed Medical Cannabis
This originally appeared at https://www.liebertpub.com/doi/10.1089/can.2018.0020 Authors Chad Purcell Andrew Davis Nico Moolman, and S. Mark Taylor Published Online:23 Sep 2019 https://doi.org/10.1089/can.2018.0020 Abstract Background: Benzodiazepines are a class of medication with sedative properties, commonly used for anxiety and other neurological conditions. These medications are associated with several well-known adverse effects. This observational study aims to investigate the reduction […]
Cannabis use in patients with fibromyalgia: effect on symptoms relief and health-related quality of life
This originally appeared at https://pubmed.ncbi.nlm.nih.gov/21533029/ Authors Jimena Fiz, Marta Durán, Dolors Capellà, Jordi Carbonell, Magí Farré Abstract Background The aim of this study was to describe the patterns of cannabis use and the associated benefits reported by patients with fibromyalgia (FM) who were consumers of this drug. In addition, the quality of life of FM […]
Cannabidiol as an adjuvant treatment in adults with drug-resistant focal epilepsy
This article originally appeared at https://pubmed.ncbi.nlm.nih.gov/37196452/ Authors Silvia Kochen 1 , Manuela Villanueva 1 , Liliana Bayarres 1 , Anilu Daza-Restrepo 1 , Silvia Gonzalez Martinez 1 , Silvia Oddo 2 Highlights Abstract Cannabidiol oil (CBD) has been approved as an anti-seizure medication for the treatment of uncommon types of epilepsy, occurring in children: Dravet syndrome, Lennox-Gastaut syndrome, and Tuberous […]
Neurodevelopmental outcomes in children after prenatal marijuana exposure
This article originally appeared at https://pubmed.ncbi.nlm.nih.gov/37283466/ Authors Oliver G Isik 1 , Ling Guo 1 , Andrew J O Whitehouse 2 , Guohua Li 1 3 , Caleb Ing 1 3 Abstract Background: The effect of prenatal marijuana exposure (PME) on child neurodevelopment remains poorly understood. Prior studies have demonstrated inconsistent results. Objectives: This study evaluated the […]
The Safety and Comparative Effectiveness of Non-Psychoactive Cannabinoid Formulations for the Improvement of Sleep
The Safety and Comparative Effectiveness of Non-Psychoactive Cannabinoid Formulations for the Improvement of Sleep: A Double-Blinded, Randomized Controlled Trial Jessica Londeree Saleska, Corey Bryant, Antonija Kolobaric, Christopher R. D’Adamo, Christopher S. Colwell, Derek Loewy Received 24 Feb 2023, Accepted 11 Apr 2023, Published online: 10 May 2023 https://doi.org/10.1080/27697061.2023.2203221 This originally appeared at https://www.tandfonline.com/doi/full/10.1080/27697061.2023.2203221 Abstract Background […]
